The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / P•••••• o• E••••••• R••••••••

C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million

Platform acquisitionannouncedannounced Mar 25, 2019Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • “E••••••• is an attractive asset commercialized by a world-class marketer and we are pleased to partner with C•••• as it advances its clinical pipeline” said A••••• R•••••••••, Managing Partner of O••••••• Capital.
  • O••••••• Capital, a private investment firm with over $1.2 billion in capital commitments since inception, is focused exclusively on investing in the global healthcare industry and specializes in flexible investment structures customized to meet the specific capital requirements and strategic object
Sell side
  • C••••Sellerconfirmed
    C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million
Side not stated
Evidence
C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million
C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million | Private Equity Intelligence | DFX